Idiopathic short stature is a common condition with a heterogeneous etiology. Advances in genetic methods, including genome sequencing techniques and bioinformatics approaches, have emerged as important tools to identify the genetic defects in families with monogenic short stature. These findings have contributed to the understanding of growth regulation and indicate that growth plate chondrogenesis, and therefore linear growth, is governed by a large number of genes important for different signaling pathways and cellular functions, including genetic defects in hormonal regulation, paracrine signaling, cartilage matrix, and fundamental cellular processes. In addition, mutations in the same gene can cause a wide phenotypic spectrum depending on the severity and mode of inheritance of the mutation.
Introduction
Longitudinal growth occurs by chondrogenesis at the growth plate and is regulated by a complex network of local and systemic factors [1] . Decreased growth plate chondrogenesis results in short stature, which is a common concern during childhood and a frequent cause for referral to pediatric endocrinologists. During evaluation for short stature, causative and modifiable factors including environmental factors, malnutrition, hormonal disorders, as well as inflammatory and other systemic diseases are identified or excluded. In addition, signs or symptoms indicative of syndromic short stature and skeletal dysplasias are noted. Still, in most cases, the specific etiologic factors or causative gene mutations remain unknown. Recent advances in large-scale genomic analysis have resulted in an improved understanding of the genetic complexity of short stature [1, 2] . For example, the most recent meta-analysis of genome-wide association studies of adult height identified 697 variants at 423 genomic loci [3, 4] , with each loci only explaining a small fraction of the variability and all loci together explaining about 20% of height heritability, thus confirming that height is a truly polygenic trait [3] . Furthermore, next-
Defects in Hormonal Signaling
Defects in genes within the growth hormone (GH)/ insulin-like growth factor (IGF)1 system can cause growth failure and short stature (Table 1) . It is essential that GH and IGF1 deficiencies are ruled out because they are treatable causes of short stature. Isolated GH deficiency (GHD) is usually caused by mutations in the gene encoding GH (GH1) and the receptor for GHRH (GHRHR). Isolated GHD may also be the only or first presentation of mutations in genes encoding early (Hesx1, Sox2, Sox3, Lhx3, Lhx4, Ptx1, Ptx2, and Otx2) or late (PROP1 and POU1F1) transcription factors important for the development of the pituitary [5] . Mutations in early transcription factors are commonly associated with other developmental abnormalities, including variants of septo-optic dysplasia and/or ocular defects (HESX1, OTX2, SOX2, and SOX3), skeletal defects (LHX3 and PITX2), and intellectual impairment (SOX3 and SOX2) with or without other pituitary hormone deficiencies [6] . Severe isolated GHD and pituitary hypoplasia can also be caused by biallelic mutations in RNPC3, which encodes a minor spliceosome protein required for U11/U12 small nuclear ribonucleoprotein (snRNP) formation and splicing of U12-type introns [7] . The BTK (Bruton tyrosine kinase) gene, a key regulator of B-cell development, has been associated with X-linked GHD associated with agammaglobulinemia [8] .
GH resistance is caused by mutations in the growth hormone receptor gene (GHR) or STAT5B [9, 10] . In contrast to GH, IGF1 and IGF1R are critical for fetal growth and brain development. Consequently, mutations in IGF1 or IGF1R cause intrauterine growth restriction, microcephaly, and various degrees of developmental delay [11] [12] [13] [14] . Mutations in IGFALS, a gene that encodes a protein that stabilizes IGF1 by forming the IGF1-IGFBP3-ALS complex, cause mild short stature associated with insulin resistance and osteoporosis [15, 16] . A novel syndrome of progressive postnatal growth failure in 2 families with markedly elevated serum concentrations of IGF1, IGFBP3, IGFBP5, acid labile subunit, and IGF2 concentrations, resulting from homozygous loss of function of PAPPA2, was recently reported [17] . Both mutations caused a complete absence of PAPPA2, a pregnancy-associated plasma protein-A2 that plays a critical role in releasing IGF1 from IGFBP3 and IGFBP5. Decreased proteolytic activity of PAPPA2 was associated to a significant increase in IGF1 bound in its ternary complex and low concentrations of free IGF1. Other findings include moderate microcephaly, thin long bones, and mildly decreased bone density [17] .
Abnormal Paracrine Signaling
Fibroblast Growth Factor and Fibroblast Growth Factor Receptor Signaling Fibroblast growth factor (FGF)-FGF receptor (FGFR) signaling is important in various cellular processes, including proliferation, differentiation, and cell survival. Binding of the FGF ligand, in concert with heparan sulfate, induces FGFR dimerization and transphosphorylation, followed by activation of downstream signal transduction pathways [18, 19] . In growth plate chondrocytes, FGFR3 signaling results in inhibition of proliferation and hypertrophy and may ultimately result in apoptosis [20] . Consequently, activating mutations in fibroblast growth factor receptor 3 (FGFR3) result in inhibition of growth, which can result in skeletal dysplasias ranging from moderate disproportionate short stature (hypochondroplasia) to severe short stature and bone malformation (achondroplasia), and to the most severe form (thanatophoric dysplasia), a lethal skeletal dysplasia with very short limbs and underdeveloped ribs [21] [22] [23] . Recently, a report of several families with autosomal dominant proportionate short stature and mild activating mutations of FGFR3 has expanded the phenotype of FGFR3 mutations [24] . Conversely, inactivating mutations in FGFR3 can cause an Horm Res Paediatr DOI: 10.1159/000455850 overgrowth syndrome including tall stature, scoliosis, camptodactyly, and hearing loss [25] [26] [27] .
Parathyroid Hormone-Related Protein and Indian Hedgehog Signaling In the growth plate, Indian hedgehog (IHH) and parathyroid hormone-related protein (PTHrP) form a feedback loop that controls the size of the proliferative pool of chondrocytes [1] . The PTHLH gene encodes PTHrp, a member of the parathyroid hormone (PTH) family, which regulates the balance between chondrocyte proliferation and the onset of hypertrophic differentiation during endochondral bone development. In humans, mutations in PTHLH are associated with brachydactyly type E2 (BDE2) [28, 29] , and inactivating mutations in its receptor (PTH1R) result in Blomstrand dysplasia, a recessive lethal chondrodysplasia characterized by very short limbs and dwarfism due to advanced skeletal maturation [30] . Interestingly, activating mutations in the same receptor cause short-limbed dwarfism, Jansen metaphyseal dysplasia, an autosomal dominant disorder accompanied by hypercalcemia and normal or low serum concentrations of PTH and PTHrP [31, 32] . Mutations in IHH, a signaling molecule, leads to brachydactyly type A1 (BDA1) [33] . Recently, mutations in the IHH gene have been reported as the cause of acrocapitofemoral dysplasia, a new autosomal recessive skeletal dysplasia characterized clinically by short stature with short limbs, coneshaped epiphyses, and premature fusion of growth plates [34, 35] .
Bone Morphogenetic Protein Signaling
Genetic defects in the TGFβ superfamily, including several bone morphogenetic proteins (BMPs) and growth differentiation factors are associated with skeletal dysplasias characterized by brachydactyly [135, 136] . Brachydactyly type A2 (BDA2) is caused by mutations in BMPR1B [36] , and mutations affecting growth differentiation factor 5 (GDF5) have been identified in several individuals with brachydactyly [37] .
WNT Signaling Pathway
The Wnt signaling pathway is an evolutionarily conserved pathway that regulates crucial aspects of cell fate determination, cell migration, cell polarity, neural patterning, and organogenesis during embryonic development [38] . Disruption of Wnt signaling through mutations in ROR2, WNT5A (the ligand of ROR2), or DVL1 genes causes Robinow syndrome, a skeletal dysplasia characterized by dysmorphic facial features, short-limbed dwarfism, vertebral segmentation, and genital hypoplasia [39] . In particular, the ROR2 protein appears to be critical for the normal formation of the skeleton, heart, and genitals [40, 41] .
C-Type Natriuretic Peptide Signaling C-natriuretic peptide (CNP) acts as an important paracrine factor in the growth plate and a positive regulator of endochondral ossification [1] . In humans, overexpression of CNP results in overgrowth [42, 43] . Conversely, homozygous inactivating mutations in natriuretic peptide receptor 2 (NPR2), the primary receptor for CNP, cause acromesomelic dysplasia, Maroteaux type [44] , whereas heterozygous mutations can present as idiopathic short stature with no or only subtle signs of a skeletal dysplasia [45, 46] . In 2 recent studies of idiopathic short stature, cohorts identified heterozygous NPR2 mutations in 0-6% of the patients [47, 48] . Interestingly, activating mutation in NPR2 can cause tall stature [47, 49] .
Insulin-Like Growth Factor 2
IGF2 is an important growth factor during intrauterine growth. In mice, disruption of the paternal Igf2 allele causes severe prenatal growth retardation, and an influence on postnatal growth has also been observed [50] . In humans, there is only 1 report of a single family with a known pathogenic mutation in this gene, causing severe growth restriction and postnatal growth failure resulting in short stature [51] . Consistent with the maternal imprinting status of IGF2, the phenotype affects only family members who have inherited the variant through paternal transmission. Furthermore, the dysmorphic features of affected family members are consistent with the hypothesis that the pathogenic mechanism of Russell-Silver syndrome (RSS), at least in part, is due to IGF2 deficiency [51] . In RSS, loss of methylation at the imprinting control region (ICR1) on chromosome 11p15.5 region results in dysregulation of the H19 gene (encoding a long noncoding RNA) and IGF2 expression, which most likely explains the growth failure and other characteristic features of RSS [52] .
Defects in Cartilage Extracellular Matrix
Mutations in genes that encode matrix collagens, proteoglycans, and noncollagenous proteins affect growth plate chondrogenesis by several mechanisms, cause growth failure with a wide phenotypic spectrum, and may also affect connective tissue beyond the growth plate, causing various skeletal and joint problems, and sometimes medical problems related to other organ systems.
Collagen Synthesis
Genetic defects of collagen formation (collagenopathies) affect almost every organ and tissue in the body. In the growth plate, the most important collagenopathies are due to mutations in genes that encode Col2, Col9, Col10, and Col11 [53] . Mutations in type II collagen (COL2A1) gene cause a spectrum of rare autosomal dominant conditions characterized by skeletal dysplasia, short stature, and ocular defects [54] [55] [56] . Premature osteoarthritis (OA) is a common feature of type II collagenopathies [57] . Mutations in glycine residues disrupt the collagen triple helix and cause disease in the heterozygous state, often with a severe phenotype, including achondrogenesis type II or hypochondrogenesis, spondyloepiphyseal dysplasia congenita, or spondyloepimetaphyseal dysplasia Strudwick type [57] . Nonsense and frameshift mutations result in haploinsufficiency and usually a less severe phenotype such as Stickler syndrome I, the most frequent type II collagenopathy. Especially the p.Arg275Cys substitution is found in all patients with COL2A1-associated Czech dysplasia [57] .
The flexible nature of type IX collagen allows it to act as a bridge that connects type II collagen with other cartilage components and interacts with matrilin-3 (MATN3) and cartilage oligomeric matrix protein (COMP) genes, important components of the extracellular matrix. Mutations in alpha 1-3 chains of type IX collagen (COL9A1, COL9A2, COL9A3), in addition to mutations in COMP and MATN3 genes, can cause multiple epiphyseal dysplasia, a relatively common skeletal dysplasia mainly involving the epiphyses of long bones and characterized by mild short stature, intermittent joint pain, and early-onset OA [58] .
Heterozygous mutations in type X collagen (Col10a1) are associated with Schmid type metaphyseal chondrodysplasia and Japanese type spondylometaphyseal dysplasia, which, apart from exhibiting a mild spinal phenotype, share striking clinical and radiographic similarities [59] [60] [61] [62] . Type XI collagen is a minor component of cartilage collagen [63] . Alterations of type XI collagen caused by mutations of the α1 chain of type XI collagen (COL11A1) gene lead to Stickler dysplasia type 2 with ocular alterations [64, 65] . Mutations in the gene coding for the α2 chain of type XI collagen (COL11A2) cause heterozy- gous and homozygous otospondylomegaepiphyseal dysplasia [66] . It is notable that heterozygous mutations in COL11A2 can cause autosomal dominant otospondylomegaepiphyseal dysplasia and nonocular Stickler syndrome type 2 as well as other nonchondrodysplasia disorders [67] .
Synthesis of Non-Collagen Matrix Proteins
Aggrecan is the most abundant proteoglycan of articular and growth plate cartilage and is crucial for their structure and function. Mutations in the aggrecan gene (ACAN) cause accelerated hypertrophic differentiation of growth plate chondrocytes [68] . Homozygous ACAN mutations have been reported in 1 family and cause a severe skeletal dysplasia characterized by extreme short stature, brachydactyly, and severe midface hypoplasia, termed spondyloepimetaphyseal dysplasia [69] . In contrast, heterozygous ACAN mutations cause mild to moderate growth failure with adult height SDS commonly in the -2 to -4 range [69] and are sometimes associated with accelerated skeletal maturation [69] or early-onset OA as in familial osteochondritis dissecans [69, 70] and spondyloepiphyseal dysplasia Kimberley type [71] .
The COMP protein is an important component of the extracellular matrix and also binds strongly to calcium, being essential for the normal development of cartilage and for its conversion to bone. COMP mutations lead to the improper folding of the COMP protein in the endoplasmic reticulum, which cannot be transported out of the cell, builds up inside the chondrocyte, and ultimately leads to early cell death and prevents normal bone growth, which causes short stature and bone abnormalities seen in pseudoachondroplasia and dominant multiple epiphyseal dysplasia [58, 69] . The abnormal cartilage probably breaks down easily, which results in early-onset OA [72] . Mutations in matrilin (MATN3) [73] are also responsible for dominant multiple epiphyseal dysplasia [58] . Mutations in the fibrillin 1 (FBN1) gene, which encode TGFβ-binding protein-like domain 5 (TB5) of FBN1, are found as a cause for geleophysic and acromicric dysplasia, both characterized by severe short stature, short extremities, and stiff joints [74, 75] . Interestingly, mutations in this gene have been described in Marfan syndrome, which is characterized by tall stature and arachnodactyly. There is some evidence that FBN1 mutations in geleophysic dysplasia, acromicric dysplasia, and Marfan syndrome enhance TGFβ signaling, and it is unclear how these defects can produce either tall stature or severe short stature [75] .
Defects in Fundamental Cellular Processes
Short stature can also result from mutations in genes involved in fundamental cellular processes that are important in all cells, not just those of the growth plate. These mutations typically impair growth and development in the fetus, leading to severe intrauterine growth retardation and postnatal growth abnormalities. These disorders often present as microcephalic primordial dwarfism, characterized by a proportionate reduction in growth, not related to GHD or other hormonal deficiencies [76] , and can be associated with microcephaly, skeletal dysplasia, distinctive facial features, and other abnormalities in diverse organ systems [77] .
In this section, due to the diversity of mechanisms involved, we have grouped the conditions in 4 subgroups: transcriptional factors, intracellular pathways, DNA repair, and cell proliferation and other fundamental processes.
Transcription Factors
SRY-related HMG-Box Gene 9 (SOX9) is a transcription factor and master regulator of chondrocyte differentiation essential for the normal development of the skeleton and nonskeletal tissues. Disruption of SOX9 causes campomelic dysplasia, a severe disorder that affects the development of the skeleton and other organ systems, and complete sex reversal in about two-thirds of patients with an XY karyotype [78] . Sox5 and Sox6 are coexpressed with Sox9 in mesenchymal cells and proliferating chondrocytes, forming a complex [79] . Inactivation of Sox5 and Sox6 in mice results in a defect in the differentiation of proliferating chondrocytes and, therefore, a major disruption in endochondral bone formation [80, 81] .
Short stature homeobox-containing gene (SHOX) encodes another transcription factor important for growth plate chondrocyte function [77] . SHOX mutations can cause a broad phenotypic spectrum. Homozygous mutations cause a severe skeletal dysplasia, Langer mesomelic dysplasia, which is characterized by severe short stature, extreme shortening of the long bones in the arms and legs (mesomelia), and Madelung deformity [82] . Heterozygous mutations in SHOX cause a milder skeletal dysplasia, Léri-Weill dyschondrosteosis [83, 84] , or can present as idiopathic short stature [85, 86] . Additionally, deficiency of SHOX protein contributes to the short stature and skeletal abnormalities seen in females with Turner syndrome, where one of the sex chromosomes, including the pseudoautosomal region 1 Horm Res Paediatr DOI: 10.1159/000455850 (PAR1), which contains SHOX, is missing or structurally altered [87] .
Other Regulators of Transcription LARP7 is a component of the small nuclear ribonucleoprotein (7SKsnRNP) complex required for the stability and function of the RNA, by regulating RNA polymerase II at a promoter to begin transcription elongation [88, 89] . Mutations in LARP7 cause severe primordial dwarfism named Alazami syndrome [90] [91] [92] . Additionally, mutations in the BRF1 gene, which encodes 1 of the 3 subunits of the RNA polymerase III transcription factor complex, cause the cerebellofaciodental syndrome, characterized by severe short stature, delayed bone age, cerebellar hypoplasia, delayed development and intellectual disability, as well as facial dysmorphic features, microcephaly, and dental anomalies [93, 94] .
CREBBP (CREB binding) and EP300 encode histone acetyltransferases, which are transcriptional coactivators involved in many signaling pathways [95] . Mutations in both genes cause most of the cases of Rubinstein-Taybi syndrome, a rare condition characterized by distinctive facial features, short stature, broad and often angulated thumbs, and moderate to severe intellectual disability [95] [96] [97] . Kabuki syndrome, a multisystem disorder that presents with short stature and characteristic facies, is caused by mutations in KMT2D (MLL2) and KDM6A genes, which disrupt normal histone methylation [98, 99] . Mutations in ANKRD11 have been associated with KBG syndrome, characterized by macrodontia, distinctive craniofacial features, short stature, skeletal anomalies, global developmental delay, seizures, and intellectual disability [100] [101] [102] . ANKRD11 provides instructions for making a protein that interacts with other proteins called histone deacetylases and inhibits ligand-dependent activation of transcription.
Intracellular Signaling
RASopathies are a group of genetic syndromes that are caused by germ-line mutations in genes that encode components or regulators of the Ras/mitogen-activated protein kinase (MAPK) pathway [103, 104] . The vast majority of these mutations result in increased signal transduction down the Ras/MAPK pathway, but usually to a lesser extent than somatic mutations associated with oncogenesis. Each syndrome exhibits unique phenotypic features, but they also share numerous overlapping phenotypic features, including characteristic facial features, short stature, cardiac defects, cutaneous abnormalities, neurocognitive delay, and a predisposition to malignancies [105] . The most common RASopathies are as follows: (1 [114, 115] ; (6) neurofibromatosis type 1, caused by haploinsufficiency of neurofibromin, which acts as a tumor suppressor [116] ; and (7) Legius syndrome (neurofibromatosis type 1-like syndrome), caused by haploinsufficiency of SPRED1 [106, 117] . Molecular analysis is beneficial to both confirm clinical diagnoses and perform follow-up according to the unique characteristics of each disorder within the RASopathies.
The RPS6KA3 gene encodes RSK2, a growth-factorregulated protein kinase that acts at the distal end of the Ras/MAPK signaling pathway [118] . Mutations in the RPS6KA3 gene cause Coffin-Lowry syndrome, a syndromic form of X-linked mental retardation, which is characterized in male patients by psychomotor and growth retardation, various skeletal anomalies, and typical facial changes [119, 120] . RPS6KA3 mutations are extremely heterogeneous and lead to loss of phosphotransferase activity in the RSK2 kinase that is directly phosphorylated and activated by ERK1/2 in response to growth factors, many polypeptide hormones, and neurotransmitters. In addition, it has recently been shown that FGFR3, by interacting with, and phosphorylating 2 tyrosine residues within the C-terminal region of RSK2, influences RSK2 activation [121] .
Mutations in FGD1 cause Aarskog-Scott syndrome, also known as faciodigitogenital dysplasia, an X-linked human disorder characterized by short stature, hypertelorism, shawl scrotum, and brachydactyly [122] . FGD1 encodes a member of the Dbl family of guanine nucleotide exchange factors that activates CDC42 (Cell Division Control protein 42 homolog) which has a core function in remodeling the extracellular matrix and in the transcriptional activation of many modulators of development [123] .
In growth plate cartilage, PTHrP delay hypertrophic differentiation and disruption of PTHrP receptor signaling result in accelerated hypertrophic differentiation, decreased proliferation, and early growth cessation [124] .
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Heterozygous loss-of-function mutations in GNAS1 lead to Albright hereditary osteodystrophy (AHO) -a disease characterized by short stature, obesity, and skeletal defects -and are sometimes associated with progressive osseous heteroplasia. The manifestations of Gs α mutations are further modified by parental inheritance because Gs α is imprinted in a tissue-specific manner. Inactivating Gs α mutations leads to pseudohypoparathyroidism type 1a (PHPIA) or pseudopseudohypoparathyroidism (PPHP). Maternal inheritance of inactivating Gs α mutations (PHPIA) or an imprinting defect that leads to a paternalspecific imprinting pattern on both parental alleles lead to renal PTH resistance due to loss of expression of Gs α from the active maternal allele in renal proximal tubules. Gs α is not imprinted in growth plate chondrocytes, and therefore mutations on either the maternal (PHPIA) or paternal (PPHP) allele result in haploinsufficiency and the AHO phenotype that is present in both PHPIA and PPHP patients. Disturbance of cyclic AMP (cAMP) signaling can also be caused by mutations in PRKAR1A (the cAMP-dependent regulatory subunit of protein kinase A) and PDE4D (phosphodiesterase 4D, cAMP-specific), which leads to acrodysostosis (Maroteaux-Malamut syndrome), a skeletal dysplasia characterized by peripheral dysostosis, short stature, midface hypoplasia, developmental delay, accompanied with or without hormone resistance, respectively [125, 126] . The skeletal dysplasia characteristic of acrodysostosis resembles the AHO seen in patients with PHPIA. In the absence of cAMP, the protein kinase A (PKA) exists as an inactive tetrameric holoenzyme. It is likely that the mechanism of reduced PKA signaling causes the hormonal and skeletal phenotype of acrodysostosis and AHO [127] .
The phosphatidylinositol 3 kinase (PI3K) signaling pathway is central to the action of many hormones and growth factors, including insulin, and is essential for the differentiation of pre-adipocytes to adipocytes [128, 129] . Mutations in the PI3K gene cause SHORT syndrome, a rare and multisystem disease characterized by short stature, anterior-chamber eye anomalies, characteristic facial features, lipodystrophy, hyperextensibility, and delayed dentition [130] [131] [132] .
DNA Repair
Four subtypes of the microcephalic primordial dwarfism Seckel syndrome (SCKL) are caused by mutations in genes related to defects in DNA repair and stability (Table 1) : ATR and ATR-ATRIP complex (SCKL1), RBBP8 (SCKL2), DNA2 (SCK8), and TRAIP (SCKL9). Mutations in the ATR gene, known as the ataxia-telangiectasia and Rad3-related protein gene, was the first gene associated with mutations in SCKL1 [133, 134] . Defects in the ATRsignaling pathway result in failed checkpoint arrests and genomic instability, which in part may be due to impaired telomere maintenance [77] . The ATRIP gene encodes ATR-Interacting Protein (ATRIP), a partner protein of ATR required for ATR stability and recruitment to the site of DNA damage, and is a novel causal genetic defect for SCKL1 [135] . Interestingly, impaired function of CEP152, besides acting in centrosome integrity, also leads to accumulation of genomic defects resulting from replicative stress through enhanced activation of ATM signaling [136] . Three other genes affected in SCKL are also involved in DNA repair, but not in the ATR mechanism. SCKL2 is caused by mutations in RBBP8 (CTIP), which encodes a nuclear protein that regulates cell proliferation and may itself be a tumor suppressor acting in the same pathway as BRCA1 in transcriptional regulation, DNA repair, and/or cell cycle checkpoint control [137] . Mutations in DNA2, a member of the DNA2/NAM7 helicase family, are involved in the maintenance of mitochondrial and nuclear DNA stability and have been found as the cause of SCKL8 [138] . Recently, identification of mutations in the TRAIP gene, encoding an E3 RING ubiquitin ligase, cause SCKL9. TRAIP relocalizes to sites of DNA damage, where it is required for optimal phosphorylation of H2AX and RPA2 during S-phase in response to ultraviolet irradiation, as well as fork progression through ultraviolet-induced DNA lesions [139] .
Nijmegen breakage syndrome is a recessive genetic disorder characterized by progressive microcephaly, intrauterine growth retardation and short stature, and an increased sensitivity to ionizing radiation and premature ovarian failure in females (Table 1) . NBS1, a product of the mutated gene in Nijmegen breakage syndrome, is one of the first factors to accumulate at sites of double-strand DNA breaks (DSB) and acts as a sensor or mediator of DSB damage responses [140, 141] . Schimke immuno-osseous dysplasia is caused by mutations in the SMARCAL1 gene and characterized by severe growth restriction, immune deficiency, as well as renal and bone marrow failure [142, 143] . SMARCAL1 is an ATPase in the SNF2 family that functions at damaged replication forks to promote their stability and restart [144] [145] [146] . Mutations in LIG4 and XRCC4 genes, also implicated in the process of DSB, have been discovered in short individuals. LIG4 syndrome is characterized by growth retardation, microcephaly, unusual facial features, developmental delay, skin anomalies, and a variable immunodeficiency [147] [148] [149] [150] results from mutations in the DNA ligase IV gene, which encodes an enzyme that plays a pivotal role in repairing DSB [151, 152] . The degree of protein truncation appears to correlate with phenotype severity of LIG4 syndrome, varying from the most severe phenotype with severe combined immunodeficiency to a global growth reduction without clinically apparent immunodeficiency before investigation [150] .
Mutations in XRCC4 cause a new syndrome named SSMED, which stands for short stature, microcephaly, and endocrine dysfunction [138, 153, 154] . The XRCC4 gene encodes a protein that functions together with DNA ligase IV and the DNA-dependent protein kinase in the repair of DSB. In addition, recessive missense mutations in the homologous DNA repair enzyme MCM9 lead to a genomic instability syndrome associated with hypergonadotropic hypogonadism and short stature, much like the XRCC4 phenotype [155] . Gonadal failure appears to be a consistent finding in a number of these DNA damage repair syndromes. Insulin resistance is also a common feature, but the precise mechanism linking it to DNA damage repair is yet to be determined. Additional forms of syndromic short stature can be caused by mutations in other DNA repair genes encoding DNA helicases and other enzymes important for DNA nucleotide excision repair and DNA cross-link repair (Table 1) .
Defect in Cell Proliferation and Other Fundamental Processes
IMAGe syndrome, originally defined as an association of intrauterine growth restriction, metaphyseal dysplasia, congenital adrenal hypoplasia, and genital anomalies, has recently been shown to be caused by "gain-of-function" mutations in the proliferating cell nuclear antigen-binding domain of the paternally imprinted cyclin-dependent kinase inhibitor 1C gene (CDKN1C) resulting in decreased proliferation [156, 157] . Interestingly, silencing mutations in the same gene can cause Beckwith-Wiedemann syndrome, an overgrowth syndrome [158] .
Majewski/microcephalic "osteodysplastic" primordial dwarfism presents with generalized bony anomalies ("osteodysplastic"), and patients reach the average length of a newborn by the age of 3 or 5 years [77] . Microcephalic "osteodysplastic" primordial dwarfism type 1 is caused by mutations in the RNU-4ATAC gene, which impairs its role in splicing a small subset of introns present in approximately 700 human genes that encode proteins with a diverse range of functions, including those involved in DNA replication and repair, transcription, RNA processing, and translation [159] .
Similarly, defects of the prereplication complex cause Meier-Gorlin syndrome, which is due to mutations in 1 of several genes (ORC1, ORC4, ORC6, CDT1, and CDC6) that governs production of the proteins in the prereplication complex [160, 161] . Interestingly, in this syndrome, tissues are disproportionately reduced in size, most readily apparent in the ears and patellae [161] . 3-M syndrome, characterized by severe pre-and postnatal growth retardation, characteristic facies, normal intelligence, and skeletal abnormalities, is caused by mutations in 1 of 3 genes, CUL7, OBSL1, and CCDC8, all core components of the 3M complex and required to regulate microtubule dynamics and genome integrity [162, 163] .
In addition, impairment of other fundamental cellular processes, including centrosome/microtubule and cytoskeleton structure, chromatin remodeling, genome stability, and steroid biosynthesis, results in a large range of syndromic short stature, some of which are listed in Table 1 .
Conclusions and Future Implications
Advances in genetic technologies allow for unbiased approaches to polygenic traits, as well as rare monogenic conditions, and have advanced the understanding of the genetic regulation of the growth plate and longitudinal bone growth [1] . These studies also point towards a new level of complexity in growth plate regulation, suggesting that genes from a multitude of different signaling pathways and cellular functions are involved.
Recent reports have highlighted that mutations in the same gene, e.g., SHOX, NPR2, ACAN, IGF1, IGF1R, and FGFR3, can cause a wide phenotypic spectrum, from skeletal dysplasias to isolated short stature, without any other characteristic features. With increasing use of genetic testing in children with growth failure, the number of children who receive the unhelpful diagnosis of idiopathic short stature will hopefully decrease. This testing includes conventional chromosome analysis and microarray analysis, to sequencing of single genes, sequencing of a panel of genes, or to exome sequencing [164] . For some disorders, identifying the causative genetic defect will enable lifestyle modifications, close follow-up to anticipate detect complications early. Moreover, identifying the genetic causes of growth failure is the first step toward the development of specific treatments tailored to the underlying pathogenic mechanisms. 
